Evaluating heart patients with previous bypass surgery for graft issues and heart disease progression
Official title: Patients With Prior Coronary Artery Bypass Graft Surgery Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease
Run by Amsterdam UMC, location VUmc · NCT04772768 · Data updated 2026-11-12
This study is trying to see how heart patients who had bypass surgery and are having chest pain again are doing over time, especially looking at issues with their grafts and heart disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Amsterdam UMC, location VUmc Academic / other |
| Locations | 1 site (Amsterdam) |
| Status | Recruiting |
| Started | August 23, 2019 |
| Main results expected | July 23, 2024 |
| Study ends | July 23, 2029 |
| Registry record updated | June 2, 2023 |
| Trial ID | NCT04772768 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients aged 18 to 90 with a history of CABG and recurrent angina symptoms.
✕Probably not a fit
Patients under 18, over 90, in cardiogenic shock, pregnant, or unable to provide informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study focuses on patients who have undergone coronary artery bypass grafting (CABG) and are experiencing recurrent ischemic symptoms. It aims to investigate the clinical outcomes of these patients, particularly looking at bypass graft failure and the progression of native coronary artery disease. Data will be collected through national registry databases, electronic medical records, and standardized telephonic assessments at 3 and 5 years follow-up. The study addresses the challenges in managing patients with recurrent angina after CABG, who often have complex medical histories and comorbidities.
Why it matters
Potential benefit: If successful, this study could improve the understanding and management of recurrent angina in patients with prior CABG, leading to better clinical outcomes.
How similar studies have gone: While there have been studies on CABG outcomes, this specific observational approach focusing on recurrent angina and graft dysfunction in this patient population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Prior coronary artery bypass grafting * One or more saphenous vein grafts * Recurrent angina symptoms Exclusion Criteria: * \<18 years of age * ≥ 90 years of age * Cardiogenic shock * Pregnancy * Failure to provide informed consent
Where it's running
-
Amsterdam University Medical Centers, Department of Cardiology
Amsterdam, Netherlands Recruiting
Study contacts
- Principal investigator: Paul Knaapen, Professor — Amsterdam University Medical Centers, Department of Cardiology
- Study coordinator: Paul Knaapen, Professor
- Email: p.knaapen@amsterdamumc.nl
- Phone: +31 20 444 0123
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Differences in Outcomes After Allograft vs Autograft in Revision ACL Repair
This study looks at whether using donor tissue (allograft) versus the patient’s own tissue (autograft) in revision ACL surgery leads to different results.
-
Ruxolitinib-enhanced haploidentical transplant for children and young adults with sickle cell disease
This trial will test whether adding ruxolitinib to a reduced-intensity haploidentical transplant lowers the risk of graft failure in children and young adults with sickle cell disease.
-
Preventing graft rejection after allogeneic stem cell transplant
This trial will try the drug emapalumab to see if it can prevent graft rejection in people judged high risk after allogeneic hematopoietic stem cell transplant.
-
See if early heart plaque can be reduced with statin and colchicine in people at risk
This trial tests whether high‑intensity statin and low‑dose colchicine, taken alone or together, can reduce heart plaque in people at risk for heart disease.
-
Donor transplant for high risk blood disorders
This study is testing if a stem cell transplant from a matched sibling can help people with high-risk blood disorders like sickle cell disease and thalassemia feel better.
-
Clinical features, treatments, and outcomes in inflammation-associated non-rapidly-progressive coronary artery disease
This study will see how current treatments, inflammation markers, and patient characteristics relate to outcomes in people with inflammation-associated non-rapidly-progressive coronary artery disease (INR-CAD).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.